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Diabetes-associated microbiota in fa/fa rats is
modified by Roux-en-Y gastric bypass
Tulika Arora1,7, Florian Seyfried2,3, Neil G Docherty4,5, Valentina Tremaroli1,
Carel W le Roux2,4,5, Rosie Perkins1 and Fredrik Bäckhed1,6
1Wallenberg Laboratory, Sahlgrenska Center for Cardiovascular and Metabolic Research, Department of
Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden;
2Department of Investigative Medicine, Imperial College London, London, UK; 3Department of General,
Visceral, Vascular and Pediatric Surgery, University Hospital of Wuerzburg, Wuerzburg, Germany; 4Diabetes
Complications Research Centre, Conway Institute, School of Medicine and Medical Science, University
College Dublin, Dublin, Ireland; 5Gastrosurgical Laboratory, Sahlgrenska Academy, University of Gothenburg,
Gothenburg, Sweden and 6Novo Nordisk Foundation Center for Basic Metabolic Research, Section for
Metabolic Receptology and Enteroendocrinology, Faculty of Health Sciences, University of Copenhagen,
Copenhagen, Denmark
Roux-en-Y gastric bypass (RYGB) and duodenal jejunal bypass (DJB), two different forms of bariatric
surgery, are associated with improved glucose tolerance, but it is not clear whether the gut
microbiota contributes to this effect. Here we used fa/fa rats as a model of impaired glucose tolerance
to investigate whether (i) the microbiota varies between fa/fa and nondiabetic fa/+ rats; (ii) the
microbiota of fa/fa rats is affected by RYGB and/or DJB; and (iii) surgically induced microbiota
alterations contribute to glucose metabolism. We observed a profound expansion of Firmicutes
(specifically, Lactobacillus animalis and Lactobacillus reuteri) in the small intestine of diabetic fa/fa
compared with nondiabetic fa/+ rats. RYGB-, but not DJB-, treated fa/fa rats exhibited greater
microbiota diversity in the ileum and lower L. animalis and L. reuteri abundance compared with sham-
operated fa/fa rats in all intestinal segments, and their microbiota composition resembled that of
unoperated fa/+ rats. To investigate the functional role of RYGB-associated microbiota alterations, we
transferred microbiota from sham- and RYGB-treated fa/fa rats to germ-free mice. The metabolic
phenotype of RYGB-treated rats was not transferred by the transplant of ileal microbiota. In contrast,
postprandial peak glucose levels were lower in mice that received cecal microbiota from RYGB-
versus sham-operated rats. Thus, diabetes-associated microbiota alterations in fa/fa rats can be
modified by RYGB, and modifications in the cecal microbiota may partially contribute to improved
glucose tolerance after RYGB.
The ISME Journal (2017) 11, 2035–2046; doi:10.1038/ismej.2017.70; published online 19 May 2017
Introduction
Roux-en-Y gastric bypass (RYGB) is an effective
treatment for morbid obesity as well as type 2
diabetes (Carlsson et al., 2012). Diabetes remission
is achieved within days of RYGB and before
significant weight loss has been achieved
(Brethauer et al., 2013; Sjostrom et al., 2014). Factors
that have been proposed to contribute to the
metabolic improvements following RYGB include
calorie restriction (Isbell et al., 2010), increased
postprandial release of glucagon-like peptide 1
(le Roux et al., 2006), enhanced circulating levels
of bile acids (Simonen et al., 2012) and alterations in
the metabolome (Mutch et al., 2009; Graessler et al.,
2013a; Arora et al., 2015). In addition, RYGB has
been shown to induce marked shifts in the intestinal
microbiota in rodents (Li et al., 2011; Liou et al.,
2013) and humans (Zhang et al., 2009; Kong et al.,
2013; Graessler et al., 2013b; Tremaroli et al., 2015).
However, it is not clear whether these alterations in
the microbiota contribute to the improvement of
glucose metabolism associated with RYGB.
Duodenal jejunal bypass (DJB) is a stomach-
sparing surgical procedure resulting in an intestinal
configuration similar to that following RYGB (Figure 1a).
DJB has been demonstrated to improve glucose
tolerance in nonobese diabetic Goto-Kakizaki rats
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(Rubino et al., 2006; Kindel et al., 2009; Speck et al.,
2011), although one study did not observe any
improvement (Gavin et al., 2011). DJB has also been
reported to promote mild improvements in glucose
tolerance in overweight humans (Cohen et al., 2012;
Klein et al., 2012). However, it is not known how this
procedure affects the gut microbiota.
Fa/fa rats are leptin receptor-deficient rats that
develop impaired glucose tolerance with age
(Ionescu et al., 1985). Earlier studies in fa/fa rats
have reported that RYGB promotes pronounced
weight loss and reduces glucose and insulin levels
(Xu et al., 2002) and DJB improves glucose tolerance
(Rubino et al., 2005; Li et al., 2013; Patel et al., 2013).
Thus, fa/fa rats represent an attractive animal model
to study surgery-induced physiological improve-
ments (Greenwood et al., 1982; Wolff et al., 2009;
Lifante et al., 2012). Little is known about how the
gut microbiota is linked to these changes in fa/fa rats,
but a recent study reported that age and microenvir-
onment affect the fecal microbiome in these rats
(Lees et al., 2014). Here, we studied the gut
microbiota of fa/fa rats along the length of the
intestine and investigated the following: (i) how the
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Figure 1 Schematic of experimental design. (a) Five groups of rats were used: unoperated fa/+ and fa/fa rats, and sham-operated, RYGB-
and DJB-treated fa/fa rats. In the sham group, gastrotomy on anterior wall of stomach and jejunostomy was performed with no
reconfiguration of the gut. Intestinal segments were collected for microbiota sequencing. (b) Ileum and cecum from sham and RYGB rats
(two donors each) were transferred to germ-free recipients (n=4–5 per donor). Magnetic resonance imaging (MRI) was performed 1 and
14 days after transplantation. An oral glucose tolerance test (OGTT) was performed and ileum and cecum from each recipient were
collected for microbiota sequencing 14 days after transplantation.
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microbiota varies between diabetic fa/fa rats and
nondiabetic fa/+ rats along the length of the intes-
tine; (ii) whether changes in the gut microbiota in fa/
fa rats can be normalized by RYGB and/or DJB; and
(iii) how the altered microbiota from different
locations in the intestine contributes to glucose
metabolism.
Materials and methods
Surgically treated rats
The five groups of rats used in the surgery experi-
ments (fa/+, fa/fa, sham-operated fa/fa, RYGB-treated
fa/fa and DJB-treated fa/fa rats) have been described
in an earlier study to assess differences in glycemic
control (Seyfried et al., 2014). Briefly, male fa/+ and
fa/fa rats were purchased from Charles River, Lyon,
France, at 6 weeks of age and were individually
housed under ambient humidity at 22 °C in a 12 h
light/dark cycle. The rats had free access to drinking
water and Purina Lab diet (Lab diet, St Louis, MO,
USA, 16.7% of calories from fat). At 12 weeks of age,
fa/fa rats were randomly allocated to an unoperated
control group or to sham, RYGB or DJB surgery
groups, and surgery was performed as described
earlier (Seyfried et al., 2014). All experiments were
approved by the Veterinary Office of the Canton
Zurich, Switzerland.
Duodenal, jejunal and ileal contents from fa/+, fa/
fa and sham-operated groups and contents from
corresponding segments (that is, biliopancreatic,
alimentary and common channel limbs) of RYGB-
and DJB-treated fa/fa rats (Figure 1a) were collected
on day 35 after surgery and snap frozen in liquid
nitrogen immediately. Colon and cecal contents from
all the groups were excised and snap frozen.
Ileal and cecal transplants
Germ-free Swiss Webster male mice aged 10 weeks
were used for all transplantation experiments
(Figure 1b). Frozen contents from the ileum and
cecum of sham- and RYGB-operated fa/fa rats were
homogenized in phosphate-buffered saline buffer
supplemented with reducing solution (0.02 M Na2S
and 1% cystein dissolved in NaHCO3 buffer). Two
separate donors from each group were selected.
Germ-free mice (four to five mice per group) were
fasted for 4 h and gavaged with the resultant slurry
(200 μl). The transplanted mice were maintained in
autoclaved individual ventilated cages with sterile
bedding and fed autoclaved food and water ad
libitum for 2 weeks. Whole-body magnetic resonance
imaging was performed on day 1 and day 14 after the
transplantation. On day 14, an oral glucose tolerance
test (OGTT) was performed in mice by oral admin-
istration of 30% D-glucose (2 g kg− 1 body weight)
after a 4 h fast. Blood was drawn from the tail vein at
0, 15, 30, 60, 90 and 120min, and blood glucose
levels were measured with a Bayer glucometer.
The ileum and cecum from colonized mice were
collected and snap frozen in liquid nitrogen and
stored at − 80 °C until further process. These proce-
dures were approved by the Ethics Committee on
Animal Care and Use in Gothenburg, Sweden.
Gut microbiota analysis
DNA was extracted from all the rat samples using
repeated bead-beating protocol as described pre-
viously (Salonen et al., 2010), and the V1–V2 region
of bacterial 16S rRNA gene was amplified using the
27 F and barcoded 338 R primers fused with 454
Titanium sequencing adaptors (Hamady et al., 2008).
Three independent 25 μl PCR reactions were per-
formed for each sample under the following condi-
tions: one cycle: 3min at 95 °C; 30 cycles: 20 s at 95 °C,
30 s at 52 °C, and 60 s at 72 °C and 10min at 72 °C.
The resulting product was checked for size and
purity on 1% agarose gel, further purified (NucleoS-
pin 740609, Macherey-Nagel, Düren, Germany), and
quantified with the Quant-iT PicoGreen dsDNA kit
(Invitrogen, Carlsbad, CA, USA). Low-yield samples
were speed vacuumed to concentrate DNA. All the
samples were pooled in equal amounts (20 ng μl− 1)
and purified again with magnetic beads (AMPure XP,
Beckman, Danvers, MA, USA) to remove short
amplification products. The purified amplicons were
sequenced in a 454 GS FLX system with Titanium
chemistry by GATC Biotech (Konstanz, Germany).
Two samples with low sequences were excluded
from analysis.
DNA was extracted from the mouse samples by the
same protocol as above. The V4 region of the 16S
rRNA gene was amplified using 515 F and 806 R
primers designed for dual indexing (Kozich et al.,
2013), 10 ng μl−1 samples were pooled (with the
same purification steps) and the Illumina MiSeq
(Illumina RTA v1.17.28; MCS v2.5) platform was
used for the analysis.
Quality-filtered 454 pyrosequencing and Illumina
reads from both experiments were analyzed using
the QIIME (Quantitative Insights Into Microbial
Ecology) software package (Caporaso et al., 2010a;
version 1.9.1) as described previously (Caesar et al.,
2015). Briefly, chimeric sequences were identified
with ChimeraSlayer (Haas et al., 2011) and excluded
from all downstream analyses. The sequences were
clustered into operational taxonomic units (OTUs) at
a 97% identity threshold using a closed-reference
OTU picking approach with UCLUST (Edgar, 2010)
against the Greengenes reference database (DeSantis
et al., 2006). Representative OTUs were aligned
using PyNAST (Caporaso et al., 2010b) and used to
build a phylogenetic tree which was used to estimate
α-, and β-diversity of samples using unweighted
UniFrac (Lozupone and Knight, 2005). Sequences
that could not be aligned with PyNAST and
singletons were excluded. To correct for differences
in sequencing depth, the same number of sequences
were randomly sub-sampled for each sample and
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used for diversity analyses. Statistical significance of
sample groupings was tested with a multivariate
nonparametric analysis of variance (Adonis, 999
permutations; Anderson, 2001). Sequence data from
the rat and mice analyses are stored in the European
Nucleotide Archive (www.ebi.ac.uk/ena) under
accession numbers PRJEB20172 and PRJEB20197,
respectively.
The online source BLAST was used to identify
V1–V2 sequences at the species level for the most
abundant and significant OTUs that had not already
been specified in the OTU table.
Statistical analysis
Data are presented as mean± s.e.m. OTUs (at six
taxonomic levels, from phylum to species level)
differing between groups were identified in QIIME
with the nonparametric Kruskal–Wallis test. To
determine the differences between groups (which
were not reported in QIIME), the OTUs that had a
P-valueo0.05 (with false discovery rate correction)
in the QIIME analysis were thereafter analyzed with
Kruskal–Wallis test with Dunn’s multiple compar-
ison to determine pair-wise differences using Graph-
Pad prism version 6 (GraphPad Software Inc.) as
reported previously (Fak et al., 2015). Statistical
comparison of two groups was performed by the
nonparametric Mann–Whitney U-test. Significance
was established at Po0.05.
Results
Composition of the gut microbiota of fa/fa rats is
modified by RYGB but not by DJB
Fasting glucose and insulin levels in the five groups of
rats used in this study (unoperated fa/+, unoperated
fa/fa, sham-operated fa/fa, RYGB-treated fa/fa and
DJB-treated fa/fa) have previously been reported: both
variables were significantly higher in unoperated fa/fa
rats compared with fa/+ rats at 17 weeks of age and
were normalized in fa/fa rats that underwent RYGB
but not in those that were sham operated (Seyfried
et al., 2014). There was a small reduction in fasting
blood glucose levels in DJB-treated fa/fa rats com-
pared with sham-operated rats, but levels remained
significantly higher than those in RYGB-treated rats
(Seyfried et al., 2014). Body weight was similar in all
groups of mice at 17 weeks of age except for the
RYGB-treated group in which body weight was
significantly lower (Seyfried et al., 2014).
To determine whether these differences between
the groups of rats were associated with changes in
the microbiota along the length of the gut, we
performed 454 sequencing on samples collected
from the duodenum, jejunum, ileum and colon of
these rats. In total, we generated 566521 reads
averaging 5665± 2086 reads per sample. Alpha
diversity (as measured by the observed species) did
not differ between fa/fa and fa/+ rats nor between
DJB-treated rats and sham-operated rats but was
significantly higher in the ileum of RYGB-treated rats
compared with sham-operated rats (Figure 2a).
Unweighted UniFrac analysis (sensitive to the
phylogenetic relatedness of taxa) on all the samples
revealed significant clustering by intestinal segment
(Adonis: R2 = 0.12, P=0.001; Figure 2b). This analy-
sis also showed that surgery could explain more
variability in the microbiota composition (Adonis:
R2 = 0.42, P=0.001) than intestinal segment; in
particular, RYGB samples formed a separate cluster
(Figure 2c). The non-phylogenetic Bray–Curtis ana-
lysis showed similar results (Supplementary
Figure S1). We also performed unweighted UniFrac
analysis on the samples divided according to
intestinal segment and observed significant cluster-
ing of samples from RYGB-treated fa/fa rats in the
duodenum (Adonis: R2 = 0.28, P=0.001), jejunum
(Adonis: R2 = 0.34, P=0.001), ileum (Adonis:
R2 = 0.41, P=0.001) and colon (Adonis: R2 = 0.31,
P=0.001; Figure 2d).
Firmicutes was the most abundant phylum in the
small intestinal regions of unoperated fa/+ rats, and
increased in abundance in unoperated fa/fa rats to
98% of the total microbial composition in the
jejunum and ileum (Figure 3a). The levels of
Firmicutes were not affected by DJB compared with
sham surgery in the small intestine of fa/fa rats, but
were significantly lower in fa/fa rats after RYGB
versus sham in the ileum (Figure 3a). Bacteroidetes
was the second-most abundant phylum in the small
intestinal regions of unoperated fa/+ rats and it
showed a trend towards lower abundance in the
duodenum, jejunum and ileum of unoperated fa/fa
compared with fa/+ rats (Figure 3a). The levels of
Bacteroidetes were not affected by DJB compared
with sham surgery in the jejunum and ileum of fa/fa
rats, but were significantly higher in fa/fa rats after
RYGB versus sham in the ileum (Figure 3a). The
abundance of the phylum Proteobacteria was sig-
nificantly higher in the jejunum of unoperated fa/+
rats and RYGB-treated fa/fa rats compared with
sham-operated fa/fa rats (Figure 3a).
By comparing the relative abundance of genera
across the five groups of rats and along the length of
the intestine, we showed that Lactobacillus was the
predominant genus in all the intestinal regions in
unoperated fa/fa, and sham-operated and DJB-treated
rats (Supplementary Figure S2). By contrast,
Lactococcus was the most abundant genus in
RYGB-treated rats in all the intestinal regions
(Supplementary Figure S2).
Supplementary Table S1 shows the taxa that
significantly differed in abundance in unoperated
fa/+ rats and RYGB-treated fa/fa rats compared with
sham-operated fa/fa rats. Using this information, we
focused on the most abundant bacterial species from
the three most predominant phyla to identify key
species that could potentially contribute to the
observed differences in phenotype between the
groups of rats. The taxa in Supplementary Table S1
included OTUs that had not earlier been identified at
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the species level, and we used BLAST to identify the
most abundant OTUs within Firmicutes, Bacteroi-
detes and Proteobacteria at the species level. Thus,
OTU 189681 was identified as Lactobacillus ani-
malis (max score = 2169, total score = 2169, query
cover = 100%, identity = 94%, E-value = 0.0); OTU
199716 was identified as Bacteroides vulgatus (max
score =2128, total score =14 827, query cover =100%,
identity =94%, E-value =0.0); and OTU 1109362 was
identified as Escherichia coli (max score =2525, total
score =17 379, query cover =100%, identity =97%,
E-value = 0.0).
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Within Firmicutes, the most abundant species that
differed across the groups of rats were L. animalis,
Lactobacillus reuteri and Lactococcus sp.
(Figures 3b–d). Both L. animalis and L. reuteri
showed a similar pattern in all the intestinal
segments investigated, with increased abundance in
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Figure 3 Microbial community shifts along the length of intestine in unoperated and operated fa/fa rats. Relative abundance of (a) major
phyla, (b) Lactobacillus animalis, (c) Lactobacillus reuteri, (d) Lactococcus sp., (e) Bacteroides vulgatus, (f) Bacteroides acidifaciens and
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sham-operated fa/fa rats compared with unoperated
fa/+ rats, no difference between DJB-treated and sham-
operated fa/fa rats, and significant reductions in
RYGB-treated compared with sham-operated fa/fa rats
(Figures 3b and c). Lactococcus sp. also showed a
similar pattern in all the intestinal segments investi-
gated, but its abundance was dramatically reduced in
sham-operated fa/fa rats compared with unoperated
fa/+ rats, not affected by DJB compared with sham
surgery, and dramatically increased in RYGB-treated
compared with sham-operated fa/fa rats (Figure 3d).
Within Bacteroidetes, the most abundant species
that differed across the groups of rats were B. vulgatus
and Bacteroides acdifaciens (Figures 3e and f). The
abundance of these species was reduced in sham-
operated fa/fa rats compared with unoperated fa/+ rats
in the duodenum, not affected by DJB compared with
sham surgery and increased in RYGB-treated com-
pared with sham-operated fa/fa rats, and the differ-
ences were most pronounced in ileum (Figures 3e and
f). Among Proteobacteria, E. coli also increased in the
jejunum, ileum and colon in RYGB-treated compared
with sham-operated fa/fa rats (Figure 3g).
Thus, RYGB surgery in fa/fa rats promoted changes
in the microbial composition along the length of the
intestine, in particular, a dramatic reduction in the
abundance of Lactobacillus species and an increase in
Bacteroides species, resulting in a microbiota compo-
sition similar to that of unoperated nondiabetic fa/+
rats. These changes (compared with sham surgery)
were not observed following DJB in fa/fa rats.
Transplanting the ileal microbiota does not transfer the
metabolic phenotype of fa/fa rats
As RYGB had the largest effect on the microbiota in
the ileum, we transferred the ileal microbiota of
sham- and RYGB-operated fa/fa rats to germ-free
mice to investigate whether the ileal microbiota
directly contributes to the metabolic phenotype of
these rats. Alpha diversity was lower in the cecum of
germ-free mice that received ileal microbiota from
sham-operated rats (termed ‘sham recipients’) com-
pared with germ-free mice that received ileal micro-
biota from RYGB-treated rats (termed ‘RYGB
recipients’; Figure 4a). Unweighted UniFrac analysis
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bacteria per gram contents in the ileum and cecum of mice (n=9) colonized with ileal microbiota from sham-operated or RYGB-treated fa/fa
rats. (d) Oral glucose tolerance test curves and (e) fat percentage gain in mice (n=9) colonized with ileal microbiota from sham-operated or
RYGB-treated fa/fa rats. Data are mean±s.e.m. *Po0.05, **Po0.01, ***Po0.001 as indicated or versus sham recipient.
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showed separation of sham and RYGB recipients
along the first principal component (Adonis:
R2 = 0.37, P=0.001, Figure 4b), indicating that the
donor ileal microbiota determines the microbiota
composition of the recipient.
Despite the lower microbial diversity in the
recipients of sham compared with RYGB ileal
microbiota, levels of colonization (that is, total
bacteria) were similar in both the groups
(Figure 4c), with higher bacterial load in the cecum
compared with the ileum. Glucose tolerance (in
response to an OGTT) was impaired and fat gain was
higher in the RYGB recipients compared with the
sham recipients (Figures 4d and e).
Transplanting the cecal microbiota transfers the
metabolic phenotype of fa/fa rats
To investigate whether the microbiota in the cecum,
which has a higher biomass and is more metabolically
active compared with the ileal microbiota, of fa/fa rats
directly contributes to the metabolic phenotype of
these rats, we transplanted the cecal microbiota of
sham- and RYGB-operated fa/fa rats into germ-free
mice and colonized the mice for 2 weeks.
Alpha diversity was lower in the cecum of
recipients of cecal microbiota from sham- versus
RYGB-operated fa/fa rats (Figure 5a). Unweighted
UniFrac analysis confirmed that samples clustered
according to the type of donor microbiota (Adonis:
R2 = 0.38, P=0.001, Figure 5b).
There were no differences in the total levels of
bacteria in the ileum or cecum of sham versus RYGB
recipient mice (Figure 5c). However, the peak glucose
concentration in the OGTT was higher in the sham
recipients than in the RYGB recipients, indicating
improved glucose tolerance in the RYGB recipients
(Figure 5d). Adiposity in sham and RYGB recipients
2 weeks after transplantation was similar (Figure 5e).
Discussion
We previously investigated the effect of surgery on
glycemic control in diabetic fa/fa rats and showed
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that (i) RYGB produces significant weight loss and
improved fasting glucose levels compared with sham
surgery; and (ii) DJB produces mild improvements
in fasting blood glucose without weight loss
(Seyfried et al., 2014). Here we studied the micro-
biota composition of these rats along the length
of the intestine to investigate potential associations
between the microbiota and glycemic control. First,
we showed an expansion of Firmicutes and
reduction in Bacteroidetes in the jejunum and ileum
of fa/fa rats compared with nondiabetic fa/+ rats.
Second, we observed that RYGB, but not DJB surgery,
in fa/fa rats promoted changes in the microbial
composition along the length of the intestine; in
particular, a dramatic reduction in the abundance of
Lactobacillus species (including L. reuteri and
L. animalis) and an increase in Lactococcus and
Bacteroides species, resulting in a microbiota com-
position similar to that of unoperated nondiabetic fa/
+ rats. Finally, by microbiota transfer to germ-free
mice, colonization with the cecal, but not the ileal,
microbiota of RYGB-treated fa/fa rats partially
transferred the phenotype of improved glycemic
control to recipient mice.
An association between Lactobacillus species
and blood glucose levels has previously been
noted in humans. For example, an increased abun-
dance of Lactobacillus species has been repor-
ted in both European (Karlsson et al., 2013;
Marlene et al., 2013) and Chinese (Le et al., 2012;
Qin et al., 2012) patients with type 2 diabetes, and
fecal Lactobacillus levels were shown to correlate
with blood glucose levels in a study of men with
varying degrees of glucose tolerance (Larsen et al.,
2010). However, it is not known whether Lactoba-
cillus contributes to type 2 diabetes or increases
merely as a consequence of the disease. Indeed,
Lactobacillus species are used as probiotics and have
been shown to improve glucose levels in mice
(Yakovlieva et al., 2015).
Although the intestinal configuration following
RYGB and DJB is similar (Figure 1), DJB did not
affect the microbiota composition compared with
sham. Microbiota changes in response to RYGB are
likely to be produced by reduced calorie intake,
changes in luminal pH and an early arrival of
undigested food in the alimentary limb. RYGB is also
accompanied by increased expression of glucose
transporter 1 in rats (Saeidi et al., 2013) and humans
(Nguyen et al., 2014), which facilitates increased
glucose uptake in the alimentary limb thus reducing
simple sugars in the intestinal lumen, which may
explain the reduced levels of Lactobacillus. By
contrast, DJB is a stomach-sparing procedure, and
thus gastric juices, stomach size in addition to calorie
intake are likely important factors in shaping the gut
microbiota.
The important contribution of a microbiota to
metabolic phenotype was first shown in germ-free
C57/BL6 mice that gained 57% of fat and exhibited
impaired glucose tolerance after 2 weeks of
colonization with cecal microbiota from a conven-
tionally raised mouse (Backhed et al., 2004), likely
due to the extra energy provided by utilization of
indigestible carbohydrates by a complex gut micro-
biota. More recent studies have shown that metabolic
phenotypes can be transferred by transplanting the
microbiota. For example, a reduction in adiposity
after RYGB can be transferred by transplanting cecal
contents from RYGB-treated mice (Liou et al., 2013)
or feces from RYGB-operated humans (Tremaroli
et al., 2015) into germ-free mice; however, these
studies did not report an effect of microbiota transfer
on glucose tolerance. Although a causal relationship
between altered gut microbiota and improved glu-
cose control after RYGB is uncertain in humans, it
has been reported that fecal transplant from lean
donors to men with metabolic syndrome improved
insulin sensitivity and increased populations of
butyrate-producing intestinal bacteria (Vrieze et al.,
2012).
In our study, the differences between the micro-
biota of sham- versus RYGB-treated fa/fa rats
were higher in the ileum than in the colon, and
we therefore speculated that the difference in
metabolic phenotype between these groups could
be transferred by transplanting the ileal micro-
biota. However, we showed that colonization of
germ-free mice with ileal microbiota from sham-
operated rats resulted in less fat gain and improved
glucose tolerance compared with recipients of
ileal microbiota from RYGB-treated rats. This
could potentially be explained by the lower diver-
sity in sham versus RYGB donor ileal micro-
biota, a phenotype that was transferred to
recipients. Microbiota with low bacterial diversity
may be less adapted to metabolize complex carbohy-
drates resulting in lower fat gain and improved
glucose tolerance.
In contrast to mice colonized with ileal microbiota,
mice colonized with cecal microbiota from sham-
operated rats showed worse glucose tolerance com-
pared with recipients of cecal microbiota from
RYGB-treated rats. Although microbial diversity
was lower in the cecum of recipients of cecal
microbiota from sham- versus RYGB-operated rats,
it was not as low as in the recipients of ileal
microbiota from sham-operated rats. Thus, bacterial
diversity may not be a limiting factor in the cecal
transfer experiments. These results suggest that
differences in cecal microbiota composition between
the sham- versus RYGB-operated rats could con-
tribute to the improved metabolic phenotype of
RYGB-operated rats.
Taken together, our results showed that the
microbiota composition of diabetic fa/fa rats along
the length of intestine was significantly altered by
RYGB but not by DJB, and resembled the microbiota
composition of fa/+ rats. Importantly, we also
showed that RYGB-induced effects on the cecal
microbiota partly contributed to improved glucose
tolerance.
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